Terumo Corp (TSE:4543) Stock Price, Trades & News

Started as a clinical thermometer producer in Japan in 1921, Terumo is a comprehensive medical device player with a diversified global revenue. Its product portfolio includes prefilled syringes, insulin patch pumps, neurovascular or cardiac vascular interventional devices, and blood processing systems. As of 2025, the cardiac and vascular business is the largest segment, contributing over 60% of its total revenue. Geographically, North America is the largest region, with 38% of Terumo's revenue.

Financial Strength

6/10

Name	Current	Vs Industry
Cash-To-Debt	0.74
Equity-to-Asset	0.69
Debt-to-Equity	0.24
Debt-to-EBITDA	1.37
Interest Coverage	53.66
Piotroski F-Score	7/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	4.25	Distress Grey Safe
Beneish M-Score	-2.5	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

10/10

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	12
	3-Year EBITDA Growth Rate	14
	3-Year EPS without NRI Growth Rate	15.7
	3-Year FCF Growth Rate	42.5
	3-Year Book Growth Rate	12.9
	Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank	14.56
	Future 3-5Y Total Revenue Growth Rate Estimate	7.22

Momentum Rank

5/10

	Name	Current	Vs Industry		Vs History
	5-Day RSI	34.46
	9-Day RSI	41.64
	14-Day RSI	45.03
	3-1 Month Momentum %	7.92
	6-1 Month Momentum %	1.85
	12-1 Month Momentum %	-5.72

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	1.59
	Quick Ratio	0.97
	Cash Ratio	0.52
	Days Inventory	214.76
	Days Sales Outstanding	62.92
	Days Payable	63.24

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	Dividend Yield %	1.37
	Dividend Payout Ratio	0.33
	3-Year Dividend Growth Rate	14.5
	Forward Dividend Yield %	1.64
	5-Year Yield-on-Cost %	2.77
	3-Year Average Share Buyback Ratio	0.3
	Shareholder Yield %	-1.53

Profitability Rank

9/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	52.54
	Operating Margin %	15.58
	Net Margin %	12.01
	EBITDA Margin %	24.47
	FCF Margin %	11.39
	OCF Margin %	20.4
	ROE %	9.33
	ROA %	6.73
	ROIC %	8.06
	3-Year ROIIC %	7.23
	ROC (Joel Greenblatt) %	23.49
	ROCE %	11.07
	Years of Profitability over Past 10-Year	10
	Moat Score	6
	Tariff Resilience Score	7

GF Value Rank

4/10

	Name	Current	Vs Industry		Vs History
	PE Ratio	23.76
	Forward PE Ratio	19.56
	PE Ratio without NRI	23.76
	Shiller PE Ratio	32.64
	Price-to-Owner-Earnings	23.66
	PEG Ratio	1.81
	PS Ratio	2.85
	PB Ratio	2.04
	Price-to-Tangible-Book	4.13
	Price-to-Free-Cash-Flow	25.06
	Price-to-Operating-Cash-Flow	13.99
	EV-to-EBIT	18.33
	EV-to-Forward-EBIT	18.47
	EV-to-EBITDA	12.02
	EV-to-Forward-EBITDA	13
	EV-to-Revenue	2.94
	EV-to-Forward-Revenue	3.45
	EV-to-FCF	25.82
	Price-to-GF-Value	0.7
	Price-to-Projected-FCF	1.37
	Price-to-DCF (Earnings Based)	1.33
	Price-to-DCF (FCF Based)	1.3
	Price-to-Median-PS-Value	0.7
	Price-to-Peter-Lynch-Fair-Value	1.51
	Price-to-Graham-Number	2.09
	Price-to-Net-Current-Asset-Value	24.22
	Earnings Yield (Greenblatt) %	5.46
	FCF Yield %	3.99
	Forward Rate of Return (Yacktman) %	18.37

Financials (Next Earnings Date:2026-08-07 Est.)

Annual Quarterly TTM

TSE:4543's 30-Y Financials

AAPL

Income Statement Breakdown FY

Annual Quarterly

Not Enough Data

AAPL

Balance Sheet Breakdown

Annual Quarterly

Not Enough Data

AAPL

Cashflow Statement Breakdown

Annual Quarterly

Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Value % YoY

Historical Operating Revenue by Geographic Region

Value % YoY

See Details

5-Step DuPont Analysis as of

Annual Quarterly

Not Enough Data

Guru Trades

See Details

Insider Trades

See Details

Peter Lynch Chart

Y-axis scale:

Log Linear

Interactive Chart

Performance

Dividend

Log

Bar

Annualized Return %

Symbol	1 Week	1 Month	3 Months	6 Months	YTD	1 Year	3 Years	5 Years	10 Years

Total Annual Return %

Symbol	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017

Terumo Corp Executives

Details

GF Value™: 円3137.22

TSE:4543

Valuation Chart

Year:

Warning Signs

Warning! GuruFocus detected 4 Good signs with 4543. Try a 7-Day Free Trial to check it out.

Analyst Estimate

Annual Quarterly

Key Statistics

	Name	Value
	Revenue (TTM) (Mil 円)	1,131,877
	EPS (TTM) (円)	92.12
	Beta	0.3401
	3-Year Sharpe Ratio	0.03
	3-Year Sortino Ratio	0.06
	Volatility %	28.83
	14-Day RSI	45.03
	14-Day ATR (円)	69.860263
	20-Day SMA (円)	2231.75
	12-1 Month Momentum %	-5.72
	52-Week Range (円)	1900 - 2818
	Shares Outstanding (Mil)	1,475.08

Piotroski F-Score Details

Year:

	Component	Result
	Piotroski F-Score	7
	Positive ROA
	Positive CFROA
	Higher ROA yoy
	CFROA > ROA
	Lower Leverage yoy
	Higher Current Ratio yoy
	Less Shares Outstanding yoy
	Higher Gross Margin yoy
	Higher Asset Turnover yoy

Terumo Corp Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Terumo Corp Stock Events

Financials Calendars

Event	Date	Price (円)
Second quarter earnings conference call for 2027	2026-11-12	In 123 days
Second quarter earnings results for 2027	2026-11-12	In 123 days
JPY 18.000000 Cash Dividend	2026-09-29	In 79 days
First quarter earnings conference call for 2027	2026-08-07	In 26 days
First quarter earnings results for 2027	2026-08-07	In 26 days
General meeting for 2026	2026-07-24 14:00	In 13 days
Annual report for 2026	2026-06-23	2,244.50 (+1.19%)
Fourth quarter earnings conference call for 2026	2026-05-15	1,930.00 (-1.03%)
Fourth quarter earnings results for 2026	2026-05-15	1,930.00 (-1.03%)
JPY 15.000000 Cash Dividend	2026-03-30	2,131.50 (+0.78%)

Show

Entries

Terumo Corp Frequently Asked Questions

What is Terumo Corp(TSE:4543)'s stock price today?

The current price of TSE:4543 is 円2189.00. The 52 week high of TSE:4543 is 円2818.00 and 52 week low is 円1900.00.

When is next earnings date of Terumo Corp(TSE:4543)?

The next earnings date of Terumo Corp(TSE:4543) is 2026-08-07 Est..

Does Terumo Corp(TSE:4543) pay dividends? If so, how much?

The Dividend Yield % of Terumo Corp(TSE:4543) is 1.37% (As of Today), Highest Dividend Payout Ratio of Terumo Corp(TSE:4543) was 0.34. The lowest was 0.21. And the median was 0.29. The Forward Dividend Yield % of Terumo Corp(TSE:4543) is 1.64%. For more information regarding to dividend, please check our Dividend Page.

Press Release

	Subject	Date
	Terumo Launches SurTract™ Safety Syringe in the United States, Powered by Roncadelle Operations' SafeR® Passive Safety Technology	2026-01-06
	Geisinger and Terumo Neuro Advance Stroke Education and Neurovascular Innovation in Recognition of World Stroke Day 2025	2025-10-29
	Terumo Interventional Systems Announces Its New OPUSWAVE® Dual Sensor Imaging System and DualView® Imaging Catheter Receive FDA 510(k) Clearance	2025-10-24
	Terumo Neuro Unveils New SOFIA™ 88 Catheter Data Demonstrating Strong Performance Compared to Other Super-Bore Catheters	2025-07-14
	Terumo Health Outcomes Announces Distribution Agreement for Caretaker Medical's VitalStream® Non-Invasive Hemodynamic Monitoring	2025-07-09
	Terumo Interventional Systems Announces Commercial Availability of Its ROADSAVER™ Carotid Stent System	2025-05-27
	Expanding a Stroke Legacy: Terumo Neuro Announces US Commercial Availability of the SOFIA™ 88 Neurovascular Support Catheter	2025-05-13
	Terumo Blood and Cell Technologies Names Patrick Daly as Chief Business Officer	2025-04-16
	Terumo Health Outcomes Now Offers FDA-Cleared Medis QFR® 3.0 Software for Coronary Physiology Assessment in the US	2025-04-16
	Terumo Neuro Receives FDA Approval for Carotid Stent System	2025-04-15

10/Page

Articles on Terumo Corp

No articles.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.